Publication | Closed Access

Value of 111In-DOTA-lanreotide and 111In-DOTA-DPhe1-Tyr3-octreotide in differentiated thyroid cancer: results of in vitro binding studies and in vivo comparison with 18F-FDG PET

Medicine18F-fdg PetThyroid DiseasePathologyDifferentiated Thyroid CancerThyroid HormoneVitro Binding StudiesOncologyRadiation OncologyNuclear MedicineCancer ResearchEndocrine-related Cancer